PSYCHOTHERAPY VERSUS PHARMACOTHERAPY FOR POSTTRAUMATIC STRESS DISORDER: SYSTEMIC REVIEW AND META-ANALYSES TO DETERMINE FIRST-LINE TREATMENTS: Research Article: Comparison of PTSD Guidelines
Abstract
BACKGROUND: Current clinical practice guidelines (CPGs) for posttraumatic stress disorder (PTSD) offer contradictory recommendations regarding use of medications or psychotherapy as first-line treatment. Direct head-to-head comparisons are lacking. METHODS: Systemic review of Medline, EMBASE, PILOTS, Cochrane Central Register of Controlled Trials, PsycINFO, and Global Health Library was conducted without language restrictions. Randomized clinical trials ≥8 weeks in duration using structured clinical interview-based outcome measures, active-control conditions (e.g. supportive psychotherapy), and intent-to-treat analysis were selected for analyses. Independent review, data abstraction, and bias assessment were performed using standardized processes. Study outcomes were grouped around conventional follow-up time periods (3, 6, and 9 months). Combined effect sizes were computed using meta-analyses for medication versus control, medication pre-/posttreatment, psychotherapy versus control, and psychotherapy pre-/posttreatment. RESULTS: Effect sizes for trauma-focused psychotherapies (TFPs) versus active control conditions were greater than medications versus placebo and other psychotherapies versus active controls. TFPs resulted in greater sustained benefit over time than medications. Sertraline, venlafaxine, and nefazodone outperformed other medications, although potential for methodological biases were high. Improvement following paroxetine and fluoxetine treatment was small. Venlafaxine and stress inoculation training (SIT) demonstrated large initial effects that decreased over time. Bupropion, citalopram, divalproex, mirtazapine, tiagabine, and topiramate failed to differentiate from placebo. Aripiprazole, divalproex, guanfacine, and olanzapine failed to differentiate from placebo when combined with an antidepressant. CONCLUSIONS: Study findings support use of TFPs over nontrauma-focused psychotherapy or medication as first-line interventions. Second-line interventions include SIT, and potentially sertraline or venlafaxine, rather than entire classes of medication, such as SSRIs. Future revisions of CPGs should prioritize studies that utilize active controls over waitlist or treatment-as-usual conditions. Direct head-to-head trials of TFPs versus sertraline or venlafaxine are needed.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Meta-analysis studies found pharmacological intervention not as effective as psychotherapy for PTSD.
“However, meta-analysis studies found pharmacological intervention not as effective as psychotherapy [25].”
From Effects of mindfulness-based cognitive therapy for Chinese adults with PTSD symptoms: protocol for a randomised controlled trial (2024) · cites this paper as [25]
The effect size of 0.91 demonstrated in this study between MDMA-assisted therapy and placebo with therapy was larger than that for any other previously identified PTSD pharmacotherapy.
“By contrast, the effect size of 0.91 demonstrated in this study between MDMA-assisted therapy and placebo with therapy was larger than that for any other previously identified PTSD pharmacotherapy16–18.”
From MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study (2021) · cites this paper as [17]
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823 · see citing works
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · see citing works
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · see citing works
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817 · see citing works
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401 · see citing works
Freeman, A. M. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1112 · Cited by 1,670 · see citing works
Foa, E. B., Rothbaum, B. O., Riggs, D. S., & Murdock, T. B. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.59.5.715 · Cited by 1,444 · see citing works
Foa, E. B., Rothbaum, B. O., Riggs, D. S., & Murdock, T. B. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.5.715 · Cited by 1,444 · cited 1× · see citing works
“Interventions that met inclusion criteria and number of studies using them included aripiprazole (1),[30] brofaromine (2),[31, 32] bupropion (1),[33] TF-CBT (2),[23, 24, 34] citalopram (1),[35] CPT (1),[36] divalproex (2),[37, 38] EMDR (2),[39, 40] fluoxetine (5),[25, 26, 41–44] guanfacine (2),[45, 46] IPT (1),[47] mi…”
MethodPsychotherapy for Military-Related PTSD: A Review of Randomized Clinical Trials
Steenkamp, M. M., Litz, B. T., Hoge, C. W., & Marmar, C. R. (2015) · JAMA · doi:10.1001/jama.2015.8370 · Cited by 958 · see citing works
Self-citationPsychological therapies for chronic post-traumatic stress disorder (PTSD) in adults
Bisson, J. I., Roberts, N. P., Andrew, M., Cooper, R., & Lewis, C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003388.pub4 · Cited by 829 · see citing works
Schnurr, P. P., Friedman, M. J., Engel, C. C., Foa, E. B., Shea, M. T., Chow, B. K., Resick, P. A., Thurston, V., Orsillo, S. M., Haug, R., et al. (2007) · JAMA · doi:10.1001/jama.297.8.820 · Cited by 813 · cited 1× · see citing works
“Examples included partial/nonstandard reporting between text and charts,[19, 20, 22–27, 32–35, 37–39, 42, 44–46, 49, 52, 56, 58, 60, 62, 63, 65–69] switching between mean/mean change,[25, 26, 38, 43–45, 48, 50, 52, 66, 69, 71–75] switching between standard deviations(SD)/confidence intervals/standard errors,[25, 26, 2…”
BackgroundEfficacy and Safety of Sertraline Treatment of Posttraumatic Stress Disorder
Brady, K. T., Pearlstein, T. B., Asnis, G. M., Baker, D. G., ROTHBAUM, B. O., Sikes, C. R., & Farfel, G. M. (2000) · JAMA · doi:10.1001/jama.283.14.1837 · Cited by 693 · see citing works
Raskind, M. A., Peskind, E. R., Kanter, E. D., Petrie, E. C., Radant, A. D., Thompson, C. E., Dobie, D. J., Hoff, D., Rein, R. J., Straits-Tröster, K. A., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.371 · Cited by 607 · see citing works
Taylor, S. J., Thordarson, D. S., Maxfield, L., Fedoroff, I. C., Lovell, K., & Ogrodniczuk, J. S. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.2.330 · Cited by 563 · see citing works
Raskind, M. A., Peskind, E. R., Hoff, D. J., Hart, K. L., Holmes, H. A., Warren, D., Shofer, J. B., O’Connell, J., Taylor, F., Gross, C., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.032 · Cited by 554 · see citing works
Davidson, J. R. T., Rothbaum, B. O., van der Kolk, B. A., Sikes, C. R., & Farfel, G. M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.485 · Cited by 470 · see citing works
Efficacy and Safety of Paroxetine Treatment for Chronic PTSD: A Fixed-Dose, Placebo-Controlled Study
Marshall, R. D., Beebe, K. L., Oldham, M., & Zaninelli, R. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.1982 · Cited by 432 · see citing works
Pharmacotherapy for post-traumatic stress disorder: Systematic review and meta-analysis
Hoskins, M., Pearce, J., Bethell, A., Dankova, L., Barbui, C., Tol, W. A., van Ommeren, M., de Jong, J., Seedat, S., Chen, H., et al. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.148551 · Cited by 418 · see citing works
McDonagh, A., Friedman, M. J., McHugo, G. J., Ford, J. D., Sengupta, A., Mueser, K. T., Demment, C. C., Fournier, D. A., Schnurr, P. P., & Descamps, M. J. (2005) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.73.3.515 · Cited by 404 · see citing works
van der Kolk, B. A., Spinazzola, J., Blaustein, M. E., Hopper, J. W., Hopper, E. K., Korn, D. L., & Simpson, W. B. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0105 · Cited by 403 · see citing works
Is Exposure Necessary? A Randomized Clinical Trial of Interpersonal Psychotherapy for PTSD
Markowitz, J. C., Petkova, E., Neria, Y., Meter, P. E. V., Zhao, Y., Hembree, E. A., Lovell, K., Biyanova, T., & Marshall, R. D. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14070908 · Cited by 383 · see citing works
Hoge, C. W., Grossman, S. H., Auchterlonie, J. L., Riviere, L. A., Milliken, C. S., & Wilk, J. E. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201300307 · Cited by 368 · see citing works
Self-citationRaskind, M. A., Peterson, K. A., Williams, T., Hoff, D. J., Hart, K. L., Holmes, H. A., Homas, D., Hill, J., Daniels, C., Calohan, J., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12081133 · Cited by 356 · see citing works
Treatment of Posttraumatic Stress Disorder With Amitriptyline and Placebo
Davidson, J. R. T. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810150059010 · Cited by 349 · see citing works
Stein, M. B., Kline, N. A., & Matloff, J. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1777 · Cited by 348 · see citing works
Bryant, R. A., Moulds, M. L., Guthrie, R. M., Dang, S. T., & Nixon, R. D. V. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.4.706 · Cited by 325 · see citing works
Paroxetine in the Treatment of Chronic Posttraumatic Stress Disorder
Tucker, P. M., Zaninelli, R., Yehuda, R., Ruggiero, L., Dillingham, K., & Pitts, C. D. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1105 · Cited by 324 · see citing works
Blanchard, E. B., Hickling, E. J., Devineni, T., Veazey, C. H., Galovski, T. E., Mundy, E., Malta, L. S., & Buckley, T. C. (2003) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(01)00131-0 · Cited by 300 · cited 1× · see citing works
“Interventions that met inclusion criteria and number of studies using them included aripiprazole (1),[30] brofaromine (2),[31, 32] bupropion (1),[33] TF-CBT (2),[23, 24, 34] citalopram (1),[35] CPT (1),[36] divalproex (2),[37, 38] EMDR (2),[39, 40] fluoxetine (5),[25, 26, 41–44] guanfacine (2),[45, 46] IPT (1),[47] mi…”
MethodGene‐Cos, N. (2006) · Psychiatric Bulletin · doi:10.1192/pb.30.9.357-a · Cited by 281 · see citing works
Carlson, J. G., Chemtob, C. M., Rusnak, K., Hedlund, N. L., & Muraoka, M. Y. (1998) · Journal of Traumatic Stress · doi:10.1023/a:1024448814268 · Cited by 257 · see citing works
Friedman, M. J., Marmar, C. R., Baker, D. G., Sikes, C. R., & Farfel, G. M. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0508 · Cited by 243 · see citing works
Surís, A., Link‐Malcolm, J., Chard, K. M., Ahn, C. W., & North, C. S. (2013) · Journal of Traumatic Stress · doi:10.1002/jts.21765 · Cited by 238 · see citing works
Treatment of Posttraumatic Stress Disorder With Venlafaxine Extended Release
Davidson, J. R. T., Baldwin, D. S., Stein, D. J., Kuper, E., Benattia, I., Ahmed, S., Pedersen, R., & Musgnung, J. J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1158 · Cited by 230 · see citing works
Krystal, J. H., Rosenheck, R. A., Cramer, J. A., Vessicchio, J. C., Jones, K. M., Vertrees, J. E., Horney, R. A., Huang, G. D., Stock, C. J., & for the Veterans Affairs Cooperative Study No. 504 Group (2011) · JAMA · doi:10.1001/jama.2011.1080 · Cited by 220 · see citing works
Davidson, J. R. T., Pearlstein, T., Londborg, P., Brady, K. T., Rothbaum, B., Bell, J., Maddock, R., Hegel, M. T., & Farfel, G. M. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.1974 · Cited by 219 · see citing works
Zohar, J., Amital, D., Miodownik, C., Kotler, M., Bleich, A., Lane, R. M., & Austin, C. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00013 · Cited by 218 · see citing works
Fluoxetine Versus Placebo in Posttraumatic Stress Disorder
Martényi, F., Brown, E. B., Zhang, H., Prakash, A., & Koke, S. C. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0305 · Cited by 215 · see citing works
Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial
Davidson, J. R. T., Weisler, R. H., Butterfield, M. I., Casat, C. D., Connor, K. M., Barnett, S. D., & Meter, S. A. V. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01411-7 · Cited by 197 · see citing works
Schneier, F. R., Neria, Y., Pavlicová, M., Hembree, E. A., Suh, E. J., Amsel, L., & Marshall, R. D. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11020321 · Cited by 187 · see citing works
Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder
Bartzokis, G., Lu, P. H., Turner, J., Mintz, J., & Saunders, C. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.039 · Cited by 181 · see citing works
Olanzapine in the treatment of post-traumatic stress disorder: a pilot study
Butterfield, M. I., Becker, M. E., Connor, K. M., Sutherland, S. M., Churchill, L. E., & Davidson, J. R. T. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200107000-00003 · Cited by 160 · see citing works
Davidson, J., Rothbaum, B. O., Tucker, P., Asnis, G., Benattia, I., & Musgnung, J. J. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000222514.71390.c1 · Cited by 157 · see citing works
Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder
Martényi, F., Brown, E. B., Zhang, H., Koke, S. C., & Prakash, A. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.181.4.315 · Cited by 130 · see citing works
Rauch, S. A. M., King, A. P. J., Abelson, J. L., Tuerk, P. W., Smith, E. R., Rothbaum, B. O., Clifton, E. G., Defever, A. M., & Liberzon, I. (2014) · Depression and Anxiety · doi:10.1002/da.22331 · Cited by 124 · see citing works
Efficacy and Safety of Topiramate Monotherapy in Civilian Posttraumatic Stress Disorder
Tucker, P. M., Trautman, R. P., Wyatt, D. B., Thompson, J. L., Wu, S., Capece, J. A., & Rosenthal, N. R. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0204 · Cited by 122 · see citing works
Baker, D. G., Diamond, B. I., Gillette, G. M., Hamner, M. B., Katzelnick, D. J., Keller, T., Mellman, T. A., Pontius, E., Rosenthal, M., Tucker, P. M., et al. (1995) · Psychopharmacology · doi:10.1007/bf02246271 · Cited by 120 · see citing works
Reich, D. B., Winternitz, S., Hennen, J. A., Watts, T., & Stanculescu, C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1204 · Cited by 119 · see citing works
Models for estimating the number of unpublished studies.
Gleser, L., & Olkin, I. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19961215)15:23 · Cited by 116 · see citing works
The Efficacy and Tolerability of Tiagabine in Adult Patients With Post-Traumatic Stress Disorder
Davidson, J. R. T., Brady, K. T., Mellman, T. A., Stein, M. B., & Pollack, M. H. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31802e5115 · Cited by 108 · see citing works
Divalproex in the Treatment of Posttraumatic Stress Disorder
Davis, L. L., Davidson, J. R. T., Ward, L. C., Bartolucci, A., Bowden, C. L., & Petty, F. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318160f83b · Cited by 102 · see citing works
Pharmacotherapy of post‐traumatic stress disorder with a novel psychotropic
Katz, R. J., Lott, M., Arbus, P., Crocq, L., Herlobsen, P., Lingjærde, O., Lopez, G. J., Loughrey, G. C., Macfarlane, D. J., McIvor, R. J., et al. (1994) · Anxiety · doi:10.1002/anxi.3070010404 · Cited by 101 · see citing works
Padala, P. R., Madison, J., Monnahan, M., Marcil, W., Price, P., Ramaswamy, S., Din, A. U., Wilson, D. R., & Petty, F. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200609000-00005 · Cited by 99 · see citing works
Marshall, R. D., Lewis-Fernandez, R., Blanco, C., Simpson, H. B., Lin, S.-H., Vermes, D., Garcia, W., Schneier, F., Neria, Y., Sanchez-Lacay, A., et al. (2007) · Depression and Anxiety · doi:10.1002/da.20176 · Cited by 98 · see citing works
ROTHBAUM, B. O., Killeen, T. K., Davidson, J. R. T., Brady, K. T., Connor, K. M., & Heekin, M. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0402 · Cited by 94 · see citing works
A Placebo-Controlled Trial of Bupropion SR in the Treatment of Chronic Posttraumatic Stress Disorder
Becker, M. E., Hertzberg, M. A., Moore, S. D., Dennis, M. F., Bukenya, D., & Beckham, J. C. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318032eaed · Cited by 84 · see citing works
No Improvement of Posttraumatic Stress Disorder Symptoms With Guanfacine Treatment
Neylan, T. C. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.12.2186 · Cited by 83 · see citing works
Connor, K. M., Davidson, J. R. T., Weisler, R. H., Zhang, W., & Abraham, K. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0265-3 · Cited by 82 · see citing works
Martényi, F., & Soldatenkova, V. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.10.007 · Cited by 79 · see citing works
A Placebo-Controlled Study of Nefazodone for the Treatment of Chronic Posttraumatic Stress Disorder
Davis, L. L., Jewell, M. E., Ambrose, S. M., Farley, J. E., English, B. A., Bartolucci, A., & Petty, F. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000125685.82219.1a · Cited by 73 · see citing works
Carey, P., Suliman, S., Ganesan, K., Seedat, S., & Stein, D. J. (2012) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2238 · Cited by 70 · see citing works
Failed Efficacy of Fluoxetine in the Treatment of Posttraumatic Stress Disorder
Martényi, F., Brown, E. B., & Caldwell, C. D. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31803308ce · Cited by 68 · see citing works
Yeh, M. S. L., Mari, J. D. J., Costa, M. C. P., Andreoli, S. B., Bressan, R. A., & Mello, M. F. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00188.x · Cited by 63 · see citing works
No Improvement of Posttraumatic Stress Disorder Symptoms With Guanfacine Treatment
Neylan, T. C., Lenoci, M., Samuelson, K. W., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.12.2186 · Cited by 61 · see citing works
Maintenance Therapy With Fluoxetine in Posttraumatic Stress Disorder
Davidson, J. R. T., Connor, K. M., Hertzberg, M. A., Weisler, R. H., Wilson, W. H., & Payne, V. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000155817.21467.6c · Cited by 54 · see citing works
A Preliminary Controlled trial of Divalproex in Posttraumatic Stress Disorder
Hamner, M. B., Faldowski, R. A., Ulmer, H. G., Horner, M. D., & Lorberbaum, J. P. (2009) · Annals of Clinical Psychiatry · doi:10.1177/104012370902100205 · Cited by 50 · see citing works
A preliminary controlled trial of divalproex in posttraumatic stress disorder.
Hamner, M. B., Faldowski, R. A., Robert, S., et al. (2009) · PubMed · Cited by 49 · see citing works
Tucker, P. M., MD, Potter-Kimball, R., RN, MS, Wyatt, D. B., Masters, B., Parker, D. E., PhD, Burgin, C. E., et al. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4179 · Cited by 49 · see citing works
Davis, L. L., MD, Ward, L. C., PhD, Rasmusson, A. M., Southwick, S. M., Newell, J. M., LCSW, PIP, Frazier, E. C., et al. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4275 · Cited by 47 · see citing works
Self-citationFani, N., Ashraf, A., Afzal, N., Jawed, F., Kitayama, N., Reed, L., & Bremner, J. D. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.037 · Cited by 44 · see citing works
Naylor, J. C., Kilts, J. D., Bradford, D. W., Strauss, J. L., Capehart, B. P., Szabo, S. T., Smith, K. D., Dunn, C. E., Conner, K. M., Davidson, J. R. T., et al. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000061 · Cited by 34 · see citing works
One- and two-year prospective follow-up of cognitive behavior therapy or supportive psychotherapy
Blanchard, E. B., Hickling, E. J., Malta, L. S., Freidenberg, B. M., Canna, M. A., Kuhn, E. R., Sykes, M. A., & Galovski, T. E. (2003) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(03)00201-8 · Cited by 29 · see citing works
Fani, N., Kitayama, N., Ashraf, A., Reed, L., Afzal, N., Jawed, F., & Bremner, J. D. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4094 · Cited by 27 · see citing works
Zatzick, D. (2012) · Depression and Anxiety · doi:10.1002/da.21912 · Cited by 11 · see citing works
Marks, I., Lovell, K., Noshirvani, H., Livanou, M., & Thrasher, S. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.4.317 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., Ot’alora G., M., Garas, W., Paleos, C., Gorman, I., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01336-3 · Cited by 1,004 · see citing works
Leichsenring, F., Steinert, C., Rabung, S., & Ioannidis, J. P. A. (2022) · World Psychiatry · doi:10.1002/wps.20941 · Cited by 485 · see citing works
Mithoefer, M. C., Feduccia, A. A., Jerome, L., Mithoefer, A., Wagner, M., Walsh, Z., Hamilton, S., Yazar-Klosinski, B., Emerson, A., & Doblin, R. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05249-5 · Cited by 359 · see citing works
RetractedExposure therapy for PTSD: A meta-analysis
McLean, C. P., Levy, H. C., Miller, M. L., & Tolin, D. F. (2022) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.102115 · Cited by 273 · see citing works
Krystal, J. H., Davis, L. L., Neylan, T. C., A. Raskind, M., Schnurr, P. P., Stein, M. B., Vessicchio, J., Shiner, B., Gleason, T. D., & Huang, G. D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.03.007 · Cited by 265 · see citing works
Gallegos, A. M., Crean, H. F., Pigeon, W. R., & Heffner, K. L. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2017.10.004 · Cited by 181 · see citing works
Feduccia, A. A., Jerome, L., Yazar-Klosinski, B., Emerson, A., Mithoefer, M. C., & Doblin, R. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00650 · Cited by 172 · see citing works
Yoga for posttraumatic stress disorder-a systematic review and meta-analysis
Cramer, H., Anheyer, D., Saha, F. J., & Dobos, G. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1650-x · Cited by 126 · see citing works
MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study
Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., Ot’alora G, M., Garas, W., Paleos, C., Gorman, I., et al. (2023) · Focus · doi:10.1176/appi.focus.23021011 · Cited by 93 · see citing works
Sayer, N. A., Rosen, C. S., Bernardy, N. C., Cook, J. M., Orazem, R. J., Chard, K. M., Mohr, D. C., Kehle-Forbes, S. M., Eftekhari, A., Crowley, J., et al. (2017) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-017-0809-y · Cited by 68 · see citing works
Raber, J., Arzy, S., Bertolus, J. B., Depue, B., Haas, H. E., Hofmann, S. G., Kangas, M., Kensinger, E., Lowry, C. A., Marusak, H. A., et al. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.015 · Cited by 62 · see citing works
MDMA and MDMA-assisted therapy
Wolfgang, A. S., Fonzo, G. A., Gray, J. C., Krystal, J. H., Grzenda, A., Widge, A. S., Kraguljac, N. V., McDonald, W. M., Rodriguez, C. I., & Nemeroff, C. B. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230681 · Cited by 62 · see citing works
Seralini, G.-E., & Jungers, G. (2021) · Toxicology Reports · doi:10.1016/j.toxrep.2021.07.014 · Cited by 57 · see citing works
Management of Posttraumatic Stress Disorder
Ostacher, M. J., & Cifu, A. S. (2019) · JAMA · doi:10.1001/jama.2018.19290 · Cited by 55 · see citing works
Treatment of posttraumatic stress disorder: Focus on pharmacotherapy
Ehret, M. (2019) · Mental Health Clinician · doi:10.9740/mhc.2019.11.373 · Cited by 53 · see citing works
Kangaslampi, S., & Peltonen, K. (2022) · Current Psychology · doi:10.1007/s12144-019-00478-5 · Cited by 45 · see citing works
“Trauma-focused interventions may perform better than nontrauma-focused psychological treatments or pharmacotherapy (Lee et al. 2016), but there is also some evidence for the effectiveness of nontrauma-focused interventions (e.g., Forst et al. 2014; Markowitz et al. 2015).”
BackgroundSmith, N. B., Doran, J. M., Sippel, L. M., & Harpaz-Rotem, I. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.01.006 · Cited by 46 · see citing works
Bajor, L. A., Balsara, C., & Osser, D. N. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114840 · Cited by 43 · see citing works
Advances in PTSD Treatment Delivery: the Role of Digital Technology in PTSD Treatment
Kuhn, E., & Owen, J. E. (2020) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-020-00207-x · Cited by 34 · see citing works
Mak, B. S. W., Zhang, D., Powell, C. L. Y. M., Leung, M. K. W., Lo, H. H. M., Yang, X., Yip, B. H. K., Lee, E. K. P., Xu, Z., & Wong, S. Y. S. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05840-x · Cited by 2 · see citing works
“However, meta-analysis studies found pharmacological intervention not as effective as psychotherapy [25].”
Background
- Authors
- Lee, D. J., Schnitzlein, C. W., Wolf, J. P., Vythilingam, M., Rasmusson, A. M., & Hoge, C. W.
- Affiliations
- Uniformed Services University of the Health Sciences (US)
- Walter Reed National Military Medical Center (US)
- United States Marine Corps (US)
- Boston University (US)
- Walter Reed Army Institute of Research (US)
- Corresponding author
- Lee, Daniel J.
- Venue
- Depression and Anxiety
- Publisher
- Hindawi Limited
- Published
- 2016-04-29
- Volume
- 33
- Issue
- 9
- Pages
- 792-806
- ISSN
- 1091-4269 (ISSN-L)
- OpenAlex
- W2344705609
- Cited by
- 416
- References
- 74
- Citations by year
- 2026: 16 · 2025: 30 · 2024: 47 · 2023: 46 · 2022: 46 · 2021: 41 · 2020: 68 · 2019: 45 · 2018: 39 · 2017: 34 · 2016: 3
- FWCI
- 53.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Depression and Anxiety (publishedVersion)
- PubMed (publishedVersion)
- Lincoln (University of Nebraska) (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Keywords
- post-traumatic stress disorder, trauma-focused psychotherapy, pharmacotherapy, sertraline, venlafaxine, paroxetine, stress inoculation training, first-line therapy, active control, antidepressants
- MeSH terms
- Venlafaxine Hydrochloride, Antidepressive Agents, Combined Modality Therapy, Humans, Piperazines, Psychotherapy, Stress Disorders, Post-Traumatic, Triazoles, Randomized Controlled Trials as Topic, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Sertraline
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review